Key Takeaways
- Radiation therapy is not chosen by machine name alone. The diagnosis, treatment intent, target, nearby organs, previous treatment and the patient's condition determine whether and how it is used.
- A course normally involves more than the treatment visits: consultation, immobilisation, simulation imaging, contouring, dose planning, plan checks, image-guided delivery and follow-up all need time.
- Anyone previously treated with radiation should obtain the earlier plan and dose files, not just a discharge summary. Overlapping fields can change what is safe now.
- External-beam treatment does not make the patient radioactive. Brachytherapy and systemic radionuclide therapy have different precautions that must be explained for the actual procedure.
- Before travelling, obtain a clinician-reviewed schedule and identify who will manage symptoms or an unplanned treatment gap. Do not book the return flight around a marketing estimate.
Content
Radiation therapy is often described as a machine delivering radiation to a tumour. For a patient, however, the decisive work happens before the machine switches on. The team must decide exactly what to treat, what to protect, how much dose to prescribe and whether the plan still makes sense alongside surgery, medicines and the patient's priorities.
China's rules require a radiotherapy provider to have the relevant licence, facilities, staff and quality-assurance arrangements. They also require imaging and pathology or other relevant examinations before treatment, a scientific treatment plan, verification of its delivery and action when delivery departs from the plan.[1][2] These are useful starting points for checking a service, but they do not establish that a particular technique is right for a particular patient.
Start with the treatment decision, not the equipment brochure
Ask the radiation oncologist to complete one sentence in plain language: “We recommend radiation to this site, with this goal, because it is expected to provide this benefit, while the main trade-offs are these risks.” The goal may be cure, lowering recurrence risk after surgery, controlling a limited site of disease, or relieving pain, bleeding, pressure or another symptom. Those goals can lead to very different doses and schedules.
Names such as IMRT, VMAT, stereotactic radiotherapy, proton therapy and heavy-ion therapy describe ways of shaping or delivering a dose; they are not rankings. Even external-beam techniques share the basic aim of covering the target while limiting dose to nearby normal tissue.[3] Proton or heavy-ion treatment is also a regulated, resource-intensive technology in China, and the national clinical-application standard sets explicit requirements for institutions, multidisciplinary capacity, staffing and prior experience.[4] A patient should therefore ask for the clinical reason for the proposed modality and the reasonable alternative—not whether it is the newest machine.
Build a radiotherapy-ready record set
A pathology report and a short cancer history are rarely enough for treatment planning. Send the receiving team:
- pathology reports and, when review is requested, information on how slides or tissue can be transferred;
- diagnostic images in original DICOM format, together with the radiology reports;
- operative notes, systemic-treatment dates and doses, and current medicines;
- implant details, especially for pacemakers, defibrillators, neurostimulators or metal close to the proposed field;
- recent blood tests and relevant organ-function results;
- details of pregnancy possibility, prior severe reactions, mobility limits or inability to lie flat;
- every previous radiotherapy site, date, dose and number of fractions.
For previous radiation, ask the former centre for the treatment summary and, where available, the DICOM-RT plan, dose, structure set and planning images. “Radiation to the chest five years ago” does not show the new team how much dose reached the spinal cord, heart, lung or other structures. If the old files cannot be recovered, say so early; reconstructing prior exposure may be uncertain and may alter a re-irradiation decision.
Why the first visit is not the first treatment
If external-beam radiation is agreed, the next appointment is often a simulation rather than a treatment. NCI describes simulation as the planning session in which the treatment area and a reproducible position are established and scans are obtained.[3] Depending on the body site, this may involve a moulded cushion, thermoplastic mask, breathing instructions, bladder or bowel preparation, contrast, or small skin marks.
The radiation oncologist then contours the target and organs at risk. A dosimetry and medical-physics team develops and checks the plan. China's occupational health standard explicitly includes patient fixation, tumour localisation, plan design, dose delivery, verification, pre-treatment identity and site checks, equipment calibration, record keeping and correction of deviations in the quality-assurance programme.[2] This planning interval is real clinical work; it should not be promised away simply to make the travel itinerary look shorter.
Before paying, request a provisional sequence with dates or ranges for:
- specialist consultation and any pathology or imaging review;
- simulation;
- plan preparation and quality checks;
- first treatment and expected number of fractions;
- on-treatment review and laboratory checks, if relevant;
- any brachytherapy, chemotherapy or other coordinated procedure;
- completion review and earliest sensible travel date.
What a treatment day usually feels like
For external-beam treatment, positioning often takes longer than radiation delivery. Staff may use room lasers, immobilisation devices and on-board imaging to reproduce the planned position. They leave the room during irradiation to limit their repeated occupational exposure, but they can see and speak with the patient. The patient should report pain, panic, coughing, breathlessness or an inability to hold the required position rather than trying to endure it silently.
External-beam radiation does not remain in the body, so the patient is not radioactive afterwards.[3] That reassurance cannot automatically be extended to temporary or permanent brachytherapy sources or to radiopharmaceutical treatment. For either of those, obtain procedure-specific written instructions about visitors, children, pregnancy, bodily fluids, travel and security screening.
Do not remove positioning marks or apply creams, powders, antiperspirants, heating pads or ice packs to the treatment area without asking the team. NCI notes that skin advice depends on the treatment and specifically recommends asking which products should be avoided before radiation.[5]
Side effects follow the body area, not a generic list
Fatigue and skin changes are common discussion points, but expected effects depend heavily on the irradiated site. Head-and-neck treatment may affect swallowing, saliva and taste; chest treatment may irritate the oesophagus or lung; abdominal or pelvic treatment may affect nausea, bowel, bladder, sexual or reproductive function. Some effects begin during treatment, others appear later, and the absence of early symptoms does not prove that no late risk exists.[6]
Ask for a site-specific plan that distinguishes:
- what is expected and can be managed at home;
- which symptom should trigger a same-day call;
- where to go at night or on weekends;
- whether fever, dehydration, uncontrolled pain, new weakness, breathing difficulty or bleeding requires urgent assessment;
- who adjusts medicines when radiation is combined with chemotherapy or another systemic treatment.
The patient should not stop attending because the skin looks worse or because fatigue increases, nor should a missed visit be “made up” independently. Treatment gaps can matter differently by cancer type, intent and schedule. Contact the radiation oncology team the same day so it can document the interruption and decide whether the plan or timetable needs adjustment.
Costs that are easy to overlook
A useful estimate separates the professional and technical parts of care. Ask whether the quoted amount includes consultation, simulation scan and contrast, immobilisation device, contouring and planning, physics quality assurance, image guidance, each fraction, weekly review, medicines, laboratory tests and the completion visit. Brachytherapy may add applicators, an operating room, anaesthesia, imaging and inpatient care. Concurrent chemotherapy creates a second set of treatment and monitoring costs.
Also clarify what happens financially if the final plan uses fewer or more fractions, if replanning is needed after anatomy changes, or if the patient becomes medically unfit. A package price without these boundaries is difficult to compare.
The treatment summary is part of the treatment
Before leaving China, request a radiation treatment summary in a language the home clinician can use. It should identify the diagnosis and intent, treated site, technique, start and finish dates, prescribed and delivered dose, dose per fraction, number of fractions, treatment interruptions, concurrent therapy, significant toxicity and the follow-up plan. ASTRO's radiotherapy safety framework assigns preparation of a treatment summary and documentation of ongoing issues to the radiation oncologist.[7]
If future care may occur elsewhere, ask whether the centre can also export relevant planning data. Keep the summary with pathology, current medicines and the name of a clinical contact. Follow-up is not merely a scan date: it should say who reviews tumour response, who monitors late effects and which team takes responsibility when a new symptom appears.
Medical disclaimer: This guide provides general educational information and does not diagnose cancer, determine radiation eligibility or recommend a dose or technique. A radiation oncologist and the relevant multidisciplinary team must review the complete case. Seek urgent local care for severe or rapidly worsening symptoms rather than delaying for international travel.
Related Hospitals
List only hospitals whose radiotherapy licence, relevant tumour service and international-patient pathway have been verified for the period in question.
Related Treatments
Link a technique only when the hospital has confirmed current availability and a radiation oncologist has explained why it fits the patient's diagnosis and treatment intent.
Related Guides
- Pathology review before cancer treatment
- Multidisciplinary cancer care and tumour boards
- Medical-record translation and DICOM transfer
- Planning follow-up after treatment abroad
FAQ
Will external-beam radiation make me radioactive?
No. The radiation is delivered while the machine is on and does not remain in the body. Brachytherapy and systemic radionuclide therapy are different; request written precautions for the exact source or medicine used.[3]
Does a five-fraction plan mean it is weaker than a thirty-fraction plan?
Not necessarily. The dose per fraction, total dose, target, nearby organs, treatment goal and supporting evidence all matter. Compare the clinical rationale and constraints, not the visit count by itself.
What should I do if illness or a travel problem makes me miss treatment?
Contact the treating department that day. Do not skip quietly, double a visit or change travel dates on your own. The radiation oncologist should assess the reason, the length of the gap and whether any schedule or plan response is appropriate.
Can I receive radiation again in an area treated years ago?
Sometimes, but the decision is highly individual. The team needs the old site and dose distribution, the time since treatment, current target and normal-tissue tolerance. Obtain prior DICOM-RT data when possible; a brief discharge note may be insufficient.
How can I compare radiotherapy centres in China?
Confirm the licence and tumour-specific team, then ask who contours the target, who performs physics checks, what image guidance is used, how urgent toxicity is handled, and what records are supplied at completion. A machine brand or advertised technology does not answer those questions.[1][2]
Sources
- National Health Commission of China — Regulation on the Administration of Radiological Diagnosis and Treatment
- National Health Commission of China — GBZ 121—2020 Requirements for Radiotherapy Protection and Quality Assurance
- US National Cancer Institute — External Beam Radiation Therapy for Cancer
- National Health Commission of China — Proton and Heavy-Ion Accelerator Radiotherapy Clinical Application Standard (2022)
- US National Cancer Institute — Skin and Nail Changes During Cancer Treatment
- US National Cancer Institute — Radiation Therapy Side Effects
- American Society for Radiation Oncology — Safety Is No Accident: A Framework for Quality Radiation Oncology Care
Hero Image Review
- Decision: Rejected; replacement pending as hero-reviewed.png.
- Why: The original is a generic consultation illustration. It contains no treatment room, positioning device, linear accelerator or other visual cue specific to radiation therapy.
- Replacement brief: Documentary-style 16:9 scene in a modern radiotherapy suite: a radiation therapist checking alignment while an adult patient lies calmly on a treatment couch beneath a realistic linear accelerator; respectful distance, no distress, readable screens, logos, beams, masks covering the face, or science-fiction effects.